Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Peter J. Richardson(BenevolentAI (United Kingdom)), Ivan Griffin(BenevolentAI (United Kingdom)), Catherine Tucker(BenevolentAI (United Kingdom)), D. Casey Smith(BenevolentAI (United Kingdom)), Olly Oechsle(BenevolentAI (United Kingdom)), Anne M. Phelan(BenevolentAI (United Kingdom)), Michael J. Rawling(BenevolentAI (United Kingdom)), Edward Savory(BenevolentAI (United Kingdom)), Justin Stebbing(Imperial College London)
The Lancet
February 1, 2020
Cited by 1,488Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis